<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06670</article-id><article-id pub-id-type="doi">10.7554/eLife.06670</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-28443"><name><surname>Blaauboer</surname><given-names>Steven M</given-names></name><aff><institution content-type="dept">Center for Immunology and Microbial Disease</institution>, <institution>Albany Medical College</institution>, <addr-line><named-content content-type="city">Albany</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28444"><name><surname>Mansouri</surname><given-names>Samira</given-names></name><aff><institution content-type="dept">Center for Immunology and Microbial Disease</institution>, <institution>Albany Medical College</institution>, <addr-line><named-content content-type="city">Albany</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28445"><name><surname>Tucker</surname><given-names>Heidi R</given-names></name><aff><institution content-type="dept">Center for Immunology and Microbial Disease</institution>, <institution>Albany Medical College</institution>, <addr-line><named-content content-type="city">Albany</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28446"><name><surname>Wang</surname><given-names>Hatti L</given-names></name><aff><institution content-type="dept">Center for Immunology and Microbial Disease</institution>, <institution>Albany Medical College</institution>, <addr-line><named-content content-type="city">Albany</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28447"><name><surname>Gabrielle</surname><given-names>Vincent D</given-names></name><aff><institution content-type="dept">Center for Immunology and Microbial Disease</institution>, <institution>Albany Medical College</institution>, <addr-line><named-content content-type="city">Albany</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-6332"><name><surname>Jin</surname><given-names>Lei</given-names></name><aff><institution content-type="dept">Center for Immunology and Microbial Disease</institution>, <institution>Albany Medical College</institution>, <addr-line><named-content content-type="city">Albany</named-content></addr-line>, <country>United States</country><email>JINL@MAIL.amc.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1164"><name><surname>Powrie</surname><given-names>Fiona M</given-names></name><role>Reviewing editor</role><aff><institution>Oxford University</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>04</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e06670</elocation-id><supplementary-material><ext-link xlink:href="elife-06670-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>25</day><month>01</month><year>2015</year></date><date date-type="accepted"><day>21</day><month>04</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Blaauboer et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Blaauboer et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Effective mucosal adjuvants enhance the magnitude and quality of the vaccine response. Cyclic di-GMP is a promising mucosal vaccine adjuvant. However, its in vivo mechanisms are unclear. Here, we showed,in mice, that cyclic di-GMP elicits stronger Ab and T<sub>H</sub> responses than the mammalian 2'3'-cyclic GMP-AMP, and generated better protection against <italic>Streptococcus pneumoniae</italic> infection than 2'3'-cyclic GMP-AMP adjuvanted vaccine. We identified two in vivo mechanisms of cyclic di-GMP. First, intranasally administered cyclic di-GMP greatly enhances Ag uptake, including pinocytosis and receptor-mediated endocytosis in vivo. The enhancement depends on MPYS (STING, MITA) expression in CD11C<sup>+</sup> cells. Second, we found that cyclic di-GMP selectively activated pinocytosis-efficient-DCs, leading to T<sub>H</sub> polarizing cytokines IL-12p70, IFNγ, IL-5, IL-13, IL-23,and IL-6 production in vivo. Notably, cyclic di-GMP induces IFNλ, but not IFNβ, in vivo. Our study revealed previously unrecognized in vivo functions of MPYS and advanced our understanding of cyclic di-GMP as a mucosal vaccine adjuvant.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All experiments with mice were performed in accordance to the regulations and approval of Albany Medical College (Albany, NY) and the Institutional Animal Care and Use Committee, ACUP NO: 1208002.</p></fn></fn-group></back></article>